TBPH - Theravance Biopharma, Inc.

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Currency in USD
Earnings EstimateCurrent Qtr. (Sep 2019)Next Qtr. (Dec 2019)Current Year (2019)Next Year (2020)
No. of Analysts5468
Avg. Estimate-1.12-1.3-4.36-3.57
Low Estimate-1.25-1.5-4.65-4.55
High Estimate-1.01-1.14-3.92-0.84
Year Ago EPS-1.1-0.92-3.99-4.36
Revenue EstimateCurrent Qtr. (Sep 2019)Next Qtr. (Dec 2019)Current Year (2019)Next Year (2020)
No. of Analysts5468
Avg. Estimate12.23M13.7M56.23M97.41M
Low Estimate7.5M9.5M42M45.7M
High Estimate20.4M24.3M76.2M260.8M
Year Ago SalesN/A15.74M60.37M56.23M
Sales Growth (year/est)N/A-12.90%-6.90%73.20%
Earnings History9/29/201812/30/20183/30/20196/29/2019
EPS Est.-1.15-1.06-1.19-1.24
EPS Actual-1.1-0.92-1.32-0.72
Difference0.050.14-0.130.52
Surprise %4.30%13.20%-10.90%41.90%
EPS TrendCurrent Qtr. (Sep 2019)Next Qtr. (Dec 2019)Current Year (2019)Next Year (2020)
Current Estimate-1.12-1.3-4.36-3.57
7 Days Ago-1.12-1.3-4.36-3.57
30 Days Ago-1.15-1.11-4.75-3.67
60 Days Ago-1.15-1.11-4.75-3.67
90 Days Ago-1.15-1.11-4.75-3.67
EPS RevisionsCurrent Qtr. (Sep 2019)Next Qtr. (Dec 2019)Current Year (2019)Next Year (2020)
Up Last 7 DaysN/AN/AN/AN/A
Up Last 30 Days4N/A64
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 DaysN/AN/AN/AN/A
Growth EstimatesTBPHIndustrySectorS&P 500
Current Qtr.-1.80%N/AN/A-0.00
Next Qtr.-41.30%N/AN/A0.08
Current Year-9.30%N/AN/A0.03
Next Year18.10%N/AN/A0.10
Next 5 Years (per annum)52.20%N/AN/A0.08
Past 5 Years (per annum)N/AN/AN/AN/A